There are 2.47 lakh active cases of coronavirus infection in the country which comprises 2.39% of the total caseload.
India has approved two COVID-19 vaccines — Serum Institute of India’s ‘Covishield’ and Bharat Biotech’s ‘Covaxin’ — for emergency restricted use, regulatory body DCGI said on Sunday. Both vaccines have to be administered in two doses, and have to be stored at 2-8° C.